If you made any changes in Pure these will be visible here soon.

Personal profile

Clinical activities

Grigoriadis as the head of the myeloma service at Monash Health has been given the responsibility to expand the program and increase the profile as a clinical trials site. Prior to his commencement in that role in 2013 there were no myeloma studies at Monash Health; Grigoriadis has actively engaged with industry and been a PI on a total of 7 studies. Grigoriadis is currently a PI on 2 open Phase III myeloma studies including lenalidomide +/- pembrolizumab and pomalidomide +/- pembrolizumab in relapsed / refractory patients.

Community service

1. Leukaemia Foundation Patient Conference, Multiple Myeloma (2012, 2014, 2015)

2. Cancer Drugs Access Committee (2016-)

Research interests

Haematology

Myeloma

Myeloid malignancies

Lymphoid malignancies

Immunology

NF-kappaB

Iron

Supervision interests

Myeloma, MDS

Monash teaching commitment

HUP3011

HUP3022

MED2042

MED1011

Research area keywords

  • Haematology
  • Myeloma
  • MDS
  • Immunology
  • NF-kappaB
  • Iron

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or
If you made any changes in Pure these will be visible here soon.